EMEA-002343-PIP01-18
Key facts
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0231/2019
|
| PIP number |
EMEA-002343-PIP01-18
|
| Condition(s) / indication(s) |
Prevention of infectious diseases caused by Corynebacterium diphtheriae, Clostridium tetani and Bordetella pertussis
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Vakzine Projekt Management GmbH
Tel.+4951116990819 |
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|